Published in AIDS Weekly, May 23rd, 2005
The study (IR101-215), conducted at 4 sites in Italy, was designed to explore the potential utility of Remune and ongoing analysis will explore immunological information. An oral presentation at the 11th Annual Conference of the British HIV Association in Dublin, Ireland, focused on data demonstrating stabilization of CD4+ cell counts, which is believed to indicate immune responses against HIV disease in antiretroviral-naive patients treated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.